Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announces that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing. The business generated $645 million in revenue in 2025 and is part of Thermo Fisher’s Specialty Diagnostics segment.
Read the full article: Thermo Fisher Scientific Signs Agreement to Sell Its Microbiology Business to Astorg //
Source: https://www.businesswire.com/news/home/20260427616368/en/Thermo-Fisher-Scientific-Signs-Agreement-to-Sell-its-Microbiology-Business-to-Astorg